Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-60,844
Closed -$3.28M 93
2016
Q3
$3.28M Sell
60,844
-6,448
-10% -$354K 1.45% 26
2016
Q2
$3.65M Sell
67,292
-598
-0.9% -$31.5K 1.64% 22
2016
Q1
$3.44M Buy
67,890
+14
+0% +$697 1.54% 26
2015
Q4
$3.5M Sell
67,876
-5,276
-7% -$269K 1.64% 22
2015
Q3
$3.52M Sell
73,152
-512
-0.7% -$26.7K 1.53% 25
2015
Q2
$3.83M Sell
73,664
-700
-0.9% -$39.4K 1.5% 25
2015
Q1
$4.29M Sell
74,364
-3,175
-4% -$182K 1.76% 20
2014
Q4
$4.14M Buy
77,539
+1,116
+1% +$62.4K 1.63% 21
2014
Q3
$4.39M Sell
76,423
-20,912
-21% -$1.28M 1.72% 24
2014
Q2
$6.51M Sell
97,335
-1,529
-2% -$103K 2.64% 5
2014
Q1
$6.6M Buy
98,864
+1,084
+1% +$73.3K 2.68% 3
2013
Q4
$6.53M Buy
97,780
+2,048
+2% +$133K 2.63% 3
2013
Q3
$6M Sell
95,732
-27,596
-22% -$1.78M 2.66% 2
2013
Q2
$7.7M Buy
+123,328
New +$7.83M 3.85% 1

Other funds holding GSK

Tealwood Asset Management's GSK Position: Q4 2016 in Review

Tealwood Asset Management sold out of GSK (GSK) in Q4 2016, closing a stake of 60,844 shares — an estimated $3.28M sold.

Tealwood Asset Management first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $7.7M in Q2 2013. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Tealwood Asset Management reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Tealwood Asset Management sold 60,844 GSK shares in Q4 2016, an estimated $3.28M.
  • Tealwood Asset Management first reported a position in GSK in Q2 2013 and held it in 14 quarters.
  • Tealwood Asset Management's GSK position peaked at $7.7M in Q2 2013.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Tealwood Asset Management's 13F filing for Q4 2016, filed 6 Feb 2017.